Oncobiona Tras

Oncobiona Tras
New tumour biomarkers
Clinical cancer research focusing on new tumour biomarkers and new molecular targets for therapeutic application in sporadic solid tumours: breast, lung, colorectal, pancreatic neuroendocrine and adenocarcinoma, and head and neck tumours.
Lines of research:
- Determination of response/resistance BMK in a variety of neoplasms.
- Early detection of premalignant lesions.
Team
Collaborators
Vera García, Ruth
Investigadora Principal del grupo Oncobiona del CHN
Publications
2019 | Clinical and Translational Oncology
2019 | Cancers
2016 | Critical Reviews in Oncology/Hematology
2014 | Critical Reviews in Oncology/Hematology
Actualidad
Projects

360º Virtual Tour
OncobionaTras
Lab

https://www.youtube.com/watch?v=adFa0CVp6pQ
REFBIO II - BMK_PANC
Antonio
Viudez Berral
Head of the Unit
Contact
Oncobiona Tras
Navarrabiomed - Centro de investigación biomédica
Complejo Hospitalario de Navarra, edificio de investigación.
Calle Irunlarrea, 3. 31008 Pamplona, Navarra, España.